top of page
Subscribe
Latest
All News
Podcast
Events
Directory
Contact
More
Use tab to navigate through the menu items.
Browse by category
All Posts
All News
Research
Spotlight
Industry & Products
Events & Training
Journal watch
Surgery News
Latest News
Top 10
obesity paradox
metabolic and bariatric surgery
Search
Studies investigate GLP-1s promise in treating substance use disorders
There have been reports that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also have the potential to treat alcohol and drug...
BMS associated with lower all-cause mortality compared with GLP-1RA treatment
Bariatric metabolic surgery (BMS) was associated with lower all-cause mortality compared with glucagon-like peptide-1 receptor agonists...
Browse by tag
obesity
(337)
337 posts
bariatric surgery
(194)
194 posts
type 2 diabetes
(100)
100 posts
weight loss
(85)
85 posts
bariatric and metabolic surgery
(79)
79 posts
semaglutide
(73)
73 posts
glucagon-like peptide (GLP-1) analogues
(59)
59 posts
SOARD
(47)
47 posts
covid-19
(40)
40 posts
Obesity Surgery
(38)
38 posts
adolescent obesity
(38)
38 posts
Journal watch
(37)
37 posts
diabetes
(36)
36 posts
childhood obesity
(35)
35 posts
product launch
(29)
29 posts
laparoscopic sleeve gastrectomy
(28)
28 posts
weight gain
(27)
27 posts
tirzepatide
(27)
27 posts
Roux-en-Y gastric bypass (RYGB)
(25)
25 posts
pregnancy
(24)
24 posts
outcomes
(23)
23 posts
Download Bariatric News issue 56
3 days ago
Ascletis completes enrolment in US study for once-monthly subcutaneous depot treatment GLP-1R agonist ASC30 for obesity
4 days ago
FDA approves Novo Nordisk’s oral semaglutide (Rybelsus) for CV risk reduction in T2DM adults
4 days ago
Back to Top
bottom of page
